TARS Tarsus Pharmaceuticals, Inc.
Nasdaq · SEC CIK 1819790 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $20.29M 29 sales by 9 insiders
- Filings on record
- 278 since 2021-08-06, latest 2026-09-17 16:47
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Azamian Bobak R. | Pres, CEO, Board COB, Dir | — | $5.51M |
| LINK WILLIAM J PHD | Dir | — | $4.48M |
| Whitfield Dianne C. | CHRO | — | $2.69M |
| Lin Elizabeth Yeu | Chief Medical Off | — | $2.36M |
| Neervannan Seshadri | COO | — | $2.00M |
| Farrow Jeffrey S | See Remarks | — | $1.32M |
| Mottiwala Aziz | Chief Commercial Off | — | $892.5K |
| Wahl Bryan | GC | — | $850.4K |
| Goodrich Katherine | Dir | — | $183.4K |
| Goldberg Andrew D. | Dir | — | — |
Transactions 236
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2026-09-17 16:47 | 2026-09-15 | TARS | PYOTT DAVID E I | Dir | M - OptEx | — | +201 | 9,575 | +2% | — |
| D | 2026-09-17 16:22 | 2026-09-15 | TARS | YARNO WENDY L | Dir | M - OptEx | — | +302 | 17.0K | +2% | — |
| DT | 2026-09-17 16:22 | 2026-09-15 | TARS | LINK WILLIAM J PHD | Dir | M - OptEx | — | +201 | 107.0K | +0.2% | — |
| DMT | 2026-09-17 16:22 | 2026-09-15 | TARS | LINK WILLIAM J PHD | Dir | S - Sale+OE | $78.38 | -12.5K | 94.5K | -12% | -$979.7K |
| MTI | 2026-09-09 16:14 | 2026-09-04 | TARS | Azamian Bobak R. | Pres, CEO, Board COB, Dir | S - Sale | $90.56 | -10.0K | 828.0K | -1% | -$905.6K |
| MT | 2026-09-09 16:13 | 2026-09-04 | TARS | Lin Elizabeth Yeu | Chief Medical Off | S - Sale | $87.50 | -10.8K | 2,547 | -81% | -$942.6K |
| MTI | 2026-09-09 16:13 | 2026-09-04 | TARS | Lin Elizabeth Yeu | Chief Medical Off | S - Sale | $87.50 | -3,180 | 1,590 | -67% | -$278.2K |
| T | 2026-09-09 16:12 | 2026-09-04 | TARS | Neervannan Seshadri | COO | S - Sale | $85.00 | -4,564 | 78.5K | -5% | -$387.9K |
| TI | 2026-09-03 16:30 | 2026-09-02 | TARS | Azamian Bobak R. | Pres, CEO, Board COB, Dir | S - Sale | $80.06 | -10.0K | 838.0K | -1% | -$800.6K |
| MT | 2026-09-03 16:29 | 2026-09-01+ | TARS | Lin Elizabeth Yeu | Chief Medical Off | S - Sale | $77.17 | -9,988 | 13.3K | -43% | -$770.8K |
| TI | 2026-09-03 16:29 | 2026-09-02 | TARS | Lin Elizabeth Yeu | Chief Medical Off | S - Sale | $80.00 | -1,590 | 4,770 | -25% | -$127.2K |
| MTI | 2026-06-22 16:09 | 2026-06-17 | TARS | Azamian Bobak R. | Pres, CEO, Board COB, Dir | S - Sale | $61.55 | -10.0K | 848.0K | -1% | -$615.5K |
| D | 2026-06-17 16:17 | 2026-06-15 | TARS | Farrow Jeffrey S | See Remarks | M - OptEx | — | +27.9K | 71.2K | +64% | — |
| D | 2026-06-17 16:17 | 2026-06-16 | TARS | Farrow Jeffrey S | See Remarks | S - Sale+OE | $60.95 | -14.4K | 56.8K | -20% | -$877.4K |
| T | 2026-06-17 16:17 | 2026-06-15 | TARS | Goodrich Katherine | Dir | S - Sale | $62.08 | -2,954 | 2,233 | -57% | -$183.4K |
| MT | 2026-06-17 16:17 | 2026-06-15 | TARS | LINK WILLIAM J PHD | Dir | S - Sale | $62.12 | -12.5K | 106.8K | -10% | -$776.5K |
| D | 2026-06-16 16:06 | 2026-06-12 | TARS | Morrison Scott W | Dir | M - OptEx | — | +2,954 | 7,638 | +63% | — |
| D | 2026-06-16 16:06 | 2026-06-12 | TARS | LINK WILLIAM J PHD | Dir | M - OptEx | — | +2,954 | 119.3K | +3% | — |
| D | 2026-06-16 16:06 | 2026-06-12 | TARS | CHAUDHURI BHASKAR | Dir | M - OptEx | — | +2,954 | 11.7K | +34% | — |
| D | 2026-06-16 16:05 | 2026-06-12 | TARS | Goodrich Katherine | Dir | M - OptEx | — | +2,954 | 5,187 | +132% | — |
| D | 2026-06-16 16:05 | 2026-06-12 | TARS | YARNO WENDY L | Dir | M - OptEx | — | +2,954 | 16.7K | +22% | — |
| D | 2026-06-16 16:05 | 2026-06-12 | TARS | Goldberg Andrew D. | Dir | M - OptEx | — | +2,954 | 19.7K | +18% | — |
| D | 2026-04-28 16:23 | 2026-04-24 | TARS | PYOTT DAVID E I | Dir | M - OptEx | — | +1,383 | 1,383 | New | — |
| 2026-03-24 | 2026-03-20 | TARS | Neervannan Seshadri | COO | S - Sale | $66.75 | -2,989 | 82.8K | -3% | -$199.5K | |
| M | 2026-03-19 | 2026-03-17+ | TARS | Azamian Bobak R. | Pres, CEO, Board COB, Dir | S - Sale | $68.34 | -34.6K | 57.1K | -38% | -$2.36M |
| M | 2026-03-19 | 2026-03-17+ | TARS | Neervannan Seshadri | COO | S - Sale | $68.21 | -11.3K | 94.0K | -11% | -$772.4K |
| M | 2026-03-19 | 2026-03-17+ | TARS | Lin Elizabeth Yeu | Chief Medical Off | S - Sale | $68.36 | -1,144 | 23.3K | -5% | -$78.2K |
| M | 2026-03-19 | 2026-03-17+ | TARS | Whitfield Dianne C. | CHRO | S - Sale | $68.36 | -12.3K | 39.2K | -24% | -$839.1K |
| M | 2026-03-19 | 2026-03-17+ | TARS | Wahl Bryan | GC | S - Sale | $68.36 | -12.4K | 72.3K | -15% | -$850.4K |
| M | 2026-03-19 | 2026-03-17+ | TARS | Mottiwala Aziz | Chief Commercial Off | S - Sale | $68.36 | -13.1K | 61.5K | -18% | -$892.5K |
| M | 2026-03-19 | 2026-03-17+ | TARS | Farrow Jeffrey S | See Remarks | S - Sale | $68.36 | -6,430 | 45.5K | -12% | -$439.6K |
| M | 2026-03-18 | 2026-03-16 | TARS | LINK WILLIAM J PHD | Dir | S - Sale | $68.79 | -12.5K | 125.2K | -9% | -$859.8K |
| D | 2026-03-17 | 2026-03-15 | TARS | Lin Elizabeth Yeu | Chief Medical Off | M - OptEx | — | +2,511 | 24.5K | +11% | — |
| D | 2026-03-17 | 2026-03-15 | TARS | Mottiwala Aziz | Chief Commercial Off | M - OptEx | — | +26.5K | 74.5K | +55% | — |
| D | 2026-03-17 | 2026-03-15 | TARS | Azamian Bobak R. | Pres, CEO, Board COB, Dir | M - OptEx | — | +66.3K | 68.0K | +3,787% | — |
| D | 2026-03-17 | 2026-03-15 | TARS | Whitfield Dianne C. | CHRO | M - OptEx | — | +23.9K | 47.3K | +102% | — |
| D | 2026-03-17 | 2026-03-15 | TARS | Neervannan Seshadri | COO | M - OptEx | — | +26.3K | 97.1K | +37% | — |
| D | 2026-03-17 | 2026-03-15 | TARS | Wahl Bryan | GC | M - OptEx | — | +24.2K | 76.4K | +46% | — |
| D | 2026-03-17 | 2026-03-15 | TARS | Farrow Jeffrey S | See Remarks | M - OptEx | — | +13.0K | 49.7K | +36% | — |
| 2026-03-05 | 2026-03-04 | TARS | Neervannan Seshadri | COO | S - Sale | $76.67 | -8,366 | 70.8K | -11% | -$641.4K | |
| D | 2026-01-14 | 2025-12-15 | TARS | Goodrich Katherine | Dir | M - OptEx | — | +2,233 | 2,233 | New | — |
| M | 2026-01-06 | 2026-01-02 | TARS | Whitfield Dianne C. | CHRO | S - Sale | $80.67 | -15.6K | 33.2K | -32% | -$1.26M |
| MI | 2025-12-30 | 2025-12-24 | TARS | Azamian Bobak R. | Pres, CEO, Board COB, Dir | S - Sale | $82.51 | -6,000 | 858.0K | -0.7% | -$495.1K |
| 2025-12-18 | 2025-12-16 | TARS | Whitfield Dianne C. | CHRO | S - Sale | $80.10 | -7,397 | 39.0K | -16% | -$592.5K | |
| I | 2025-12-18 | 2025-12-16 | TARS | Neervannan Seshadri | COO | G - Gift | $0.00 | +475 | 475 | New | $0 |
| 2025-12-18 | 2025-12-16 | TARS | Neervannan Seshadri | COO | G - Gift | $0.00 | -950 | 79.2K | -1% | $0 | |
| M | 2025-12-17 | 2025-12-15 | TARS | LINK WILLIAM J PHD | Dir | S - Sale | $81.43 | -12.5K | 130.0K | -9% | -$1.02M |
| MI | 2025-12-17 | 2025-12-15 | TARS | LINK WILLIAM J PHD | Dir | S - Sale | $81.07 | -10.4K | 0 | -100% | -$846.9K |
| D | 2025-12-17 | 2025-12-16 | TARS | Lin Elizabeth Yeu | Chief Medical Off | S - Sale+OE | $79.50 | -2,078 | 21.9K | -9% | -$165.2K |
| D | 2025-12-17 | 2025-12-15 | TARS | Lin Elizabeth Yeu | Chief Medical Off | M - OptEx | — | +6,819 | 24.0K | +40% | — |
| 2025-12-08 | 2025-12-04 | TARS | Azamian Bobak R. | Pres, CEO, Board COB, Dir | G - Gift | $0.00 | -51.9K | 1,750 | -97% | $0 | |
| I | 2025-09-26 | 2025-09-24 | TARS | Azamian Bobak R. | Pres, CEO, Board COB, Dir | S - Sale | $55.37 | -6,000 | 812.1K | -0.7% | -$332.2K |
| 2025-09-18 | 2025-09-16 | TARS | LINK WILLIAM J PHD | Dir | G - Gift | $0.00 | -2,000 | 141.3K | -1% | $0 | |
| D | 2025-09-16 | 2025-09-15 | TARS | Morrison Scott W | Dir | M - OptEx | — | +1,334 | 4,684 | +40% | — |
| 2025-09-10 | 2025-09-08 | TARS | LINK WILLIAM J PHD | Dir | S - Sale | $57.00 | -27.1K | 143.3K | -16% | -$1.55M | |
| I | 2025-08-13 | 2025-08-11 | TARS | Azamian Bobak R. | Pres, CEO, Board COB, Dir | S - Sale | $50.00 | -6,000 | 818.1K | -0.7% | -$300.0K |
| D | 2025-06-18 | 2025-06-16 | TARS | Farrow Jeffrey S | See Remarks | M - OptEx | — | +27.9K | 50.3K | +124% | — |
| D | 2025-06-18 | 2025-06-17 | TARS | Farrow Jeffrey S | See Remarks | S - Sale+OE | $40.42 | -13.6K | 36.7K | -27% | -$550.0K |
| D | 2025-06-17 | 2025-06-13 | TARS | Lin Elizabeth Yeu | Chief Medical Off | M - OptEx | — | +3,350 | 8,700 | +63% | — |
| D | 2025-06-17 | 2025-06-16 | TARS | Lin Elizabeth Yeu | Chief Medical Off | S - Sale+OE | $41.08 | -1,006 | 7,694 | -12% | -$41.3K |
| D | 2025-06-16 | 2025-06-13 | TARS | CHAUDHURI BHASKAR | Dir | M - OptEx | — | +3,350 | 8,700 | +63% | — |
| D | 2025-06-16 | 2025-06-13 | TARS | YARNO WENDY L | Dir | M - OptEx | — | +3,350 | 13.7K | +32% | — |
| D | 2025-06-16 | 2025-06-13 | TARS | Morrison Scott W | Dir | M - OptEx | — | +3,350 | 3,350 | New | — |
| D | 2025-06-16 | 2025-06-13 | TARS | Goldberg Andrew D. | Dir | M - OptEx | — | +3,350 | 16.7K | +25% | — |
| D | 2025-06-16 | 2025-06-13 | TARS | LINK WILLIAM J PHD | Dir | M - OptEx | — | +3,350 | 170.4K | +2% | — |
| 2025-06-11 | 2025-06-09 | TARS | Mottiwala Aziz | Chief Commercial Off | S - Sale | $43.76 | -17.5K | 47.6K | -27% | -$765.8K | |
| I | 2025-03-26 | 2025-03-24 | TARS | Azamian Bobak R. | Pres, CEO, Board COB, Dir | S - Sale | $50.00 | -6,000 | 824.1K | -0.7% | -$300.0K |
| M | 2025-03-20 | 2025-03-18+ | TARS | Neervannan Seshadri | COO | S - Sale | $47.89 | -7,583 | 79.7K | -9% | -$363.1K |
| M | 2025-03-20 | 2025-03-18+ | TARS | Mottiwala Aziz | Chief Commercial Off | S - Sale | $47.88 | -10.6K | 68.4K | -13% | -$505.9K |
| M | 2025-03-20 | 2025-03-18+ | TARS | Farrow Jeffrey S | See Remarks | S - Sale | $47.88 | -3,724 | 22.4K | -14% | -$178.3K |
| M | 2025-03-20 | 2025-03-18+ | TARS | Whitfield Dianne C. | CHRO | S - Sale | $47.88 | -6,711 | 46.4K | -13% | -$321.3K |
| M | 2025-03-20 | 2025-03-18+ | TARS | Wahl Bryan | GC | S - Sale | $47.88 | -9,686 | 58.1K | -14% | -$463.8K |
| M | 2025-03-20 | 2025-03-18+ | TARS | Azamian Bobak R. | Pres, CEO, Board COB, Dir | S - Sale | $48.03 | -24.2K | 70.7K | -26% | -$1.16M |
| D | 2025-03-18 | 2025-03-15 | TARS | Wahl Bryan | GC | M - OptEx | — | +19.2K | 61.4K | +46% | — |
| D | 2025-03-18 | 2025-03-15 | TARS | Azamian Bobak R. | Pres, CEO, Board COB, Dir | M - OptEx | — | +51.4K | 77.9K | +194% | — |
| D | 2025-03-18 | 2025-03-15 | TARS | Neervannan Seshadri | COO | M - OptEx | — | +21.3K | 87.3K | +32% | — |
| D | 2025-03-18 | 2025-03-15 | TARS | Whitfield Dianne C. | CHRO | M - OptEx | — | +18.9K | 53.1K | +55% | — |
| D | 2025-03-18 | 2025-03-15 | TARS | Mottiwala Aziz | Chief Commercial Off | M - OptEx | — | +21.0K | 75.6K | +38% | — |
| D | 2025-03-18 | 2025-03-15 | TARS | Farrow Jeffrey S | See Remarks | M - OptEx | — | +8,019 | 26.2K | +44% | — |
| D | 2025-03-11 | 2025-03-07 | TARS | Goldberg Andrew D. | Dir | M - OptEx | $12.89 | +7,000 | 13.3K | +110% | +$90.2K |
| 2024-10-02 | 2024-09-30 | TARS | Morrison Scott W | Dir | G - Gift | $0.00 | -6,016 | 0 | -100% | $0 | |
| D | 2024-09-17 | 2024-09-15 | TARS | Morrison Scott W | Dir | M - OptEx | — | +1,333 | 6,016 | +28% | — |
| MI | 2024-08-14 | 2024-08-12 | TARS | LINK WILLIAM J PHD | Dir | S - Sale | $26.08 | -35.0K | 0 | -100% | -$913.0K |
| MI | 2024-08-14 | 2024-08-12 | TARS | LINK WILLIAM J PHD | Dir | J - Other | $0.00 | -64.4K | 35.0K | -65% | $0 |
| 2024-08-14 | 2024-08-12 | TARS | LINK WILLIAM J PHD | Dir | J - Other | $0.00 | +27.1K | 167.1K | +19% | $0 | |
| D | 2024-06-25 | 2024-06-24 | TARS | YARNO WENDY L | Dir | M - OptEx | — | +3,350 | 10.3K | +48% | — |
| D | 2024-06-25 | 2024-06-24 | TARS | Lin Elizabeth Yeu | Dir | M - OptEx | — | +3,350 | 5,350 | +168% | — |
| D | 2024-06-25 | 2024-06-24 | TARS | Goldberg Andrew D. | Dir | M - OptEx | — | +3,350 | 6,350 | +112% | — |
| D | 2024-06-25 | 2024-06-24 | TARS | Morrison Scott W | Dir | M - OptEx | — | +3,350 | 4,683 | +251% | — |
| D | 2024-06-25 | 2024-06-24 | TARS | LINK WILLIAM J PHD | Dir | M - OptEx | — | +3,350 | 140.0K | +2% | — |
| D | 2024-06-25 | 2024-06-24 | TARS | Crane Rosemary A | Dir | M - OptEx | — | +3,350 | 5,350 | +168% | — |
| D | 2024-06-25 | 2024-06-24 | TARS | CHAUDHURI BHASKAR | Dir | M - OptEx | — | +3,350 | 5,350 | +168% | — |
| D | 2024-06-20 | 2024-06-17 | TARS | Farrow Jeffrey S | See Remarks | M - OptEx | — | +27.9K | 28.6K | +3,983% | — |
| D | 2024-06-20 | 2024-06-18 | TARS | Farrow Jeffrey S | See Remarks | S - Sale+OE | $27.47 | -10.4K | 18.1K | -37% | -$286.9K |
| D | 2024-03-19 | 2024-03-15 | TARS | Azamian Bobak R. | Pres, CEO, Board COB, Dir | M - OptEx | — | +28.3K | 36.9K | +329% | — |
| D | 2024-03-19 | 2024-03-18 | TARS | Azamian Bobak R. | Pres, CEO, Board COB, Dir | S - Sale+OE | $30.60 | -10.4K | 26.5K | -28% | -$318.7K |
| D | 2024-03-19 | 2024-03-18 | TARS | Mottiwala Aziz | Chief Commercial Off | S - Sale+OE | $30.60 | -4,766 | 54.1K | -8% | -$145.8K |
| D | 2024-03-19 | 2024-03-15 | TARS | Mottiwala Aziz | Chief Commercial Off | M - OptEx | — | +12.9K | 58.8K | +28% | — |
| D | 2024-03-19 | 2024-03-18 | TARS | Whitfield Dianne C. | CHRO | S - Sale+OE | $30.60 | -4,314 | 34.2K | -11% | -$132.0K |
| D | 2024-03-19 | 2024-03-15 | TARS | Whitfield Dianne C. | CHRO | M - OptEx | — | +11.7K | 38.5K | +44% | — |
Purchase Sale Sale after option exercise All abbreviations